Go Beyond The Vial: Medicare Policy Experts Urge Big Thinking On Drug Pricing
Executive Summary
NASEM is expected to issue a highly anticipated report in early 2021 on solutions to address Rx vial drug wastage.
You may also be interested in...
Medicaid’s Multiple Best Price Proposal Needs More Clarity Before Advancing, PhRMA Argues
Medicaid should go back to the drawing board on a key part of its proposal aimed at circumventing best price reporting obstacles to value-based purchasing.
Biden-Sanders ‘Unity Platform’: Moderate On Coverage, Extreme On Drug Pricing
The US Democratic Party will not be rallying around ‘Medicare for All’ in November. But the absence of a push for a single payer system is about the only good news for drug companies in the ‘unity platform’ released by presumptive Presidential nominee Joe Biden and his defeated rival Bernie Sanders.
Rx Vial Size: FDA Stresses Safety Issues Amid Push To Find Savings For Payors
There may be significant savings from eliminating wasteful packaging for high cost specialty drugs. The US FDA, however, is urging policy makers not to overlook the importance of patient safety in packaging issues.